697 related articles for article (PubMed ID: 27907114)
1. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
[TBL] [Abstract][Full Text] [Related]
2. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
[TBL] [Abstract][Full Text] [Related]
3. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
[TBL] [Abstract][Full Text] [Related]
4. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
[TBL] [Abstract][Full Text] [Related]
5. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
Kim AA; Rehle T
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic factors explain suboptimal adherence to antiretroviral therapy among HIV-infected Australian adults with viral suppression.
Siefried KJ; Mao L; Kerr S; Cysique LA; Gates TM; McAllister J; Maynard A; de Wit J; Carr A;
PLoS One; 2017; 12(4):e0174613. PubMed ID: 28369066
[TBL] [Abstract][Full Text] [Related]
7. Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
Kim AA; Mukui I; Young PW; Mirjahangir J; Mwanyumba S; Wamicwe J; Bowen N; Wiesner L; Ng'ang'a L; De Cock KM;
AIDS; 2016 Nov; 30(17):2685-2695. PubMed ID: 27782965
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.
Haas AD; Radin E; Hakim AJ; Jahn A; Philip NM; Jonnalagadda S; Saito S; Low A; Patel H; Schwitters AM; Rogers JH; Frederix K; Kim E; Bello G; Williams DB; Parekh B; Sachathep K; Barradas DT; Kalua T; Birhanu S; Musuka G; Mugurungi O; Tippett Barr BA; Sleeman K; Mulenga LB; Thin K; Ao TT; Brown K; Voetsch AC; Justman JE
J Int AIDS Soc; 2020 Nov; 23(11):e25631. PubMed ID: 33225559
[TBL] [Abstract][Full Text] [Related]
9. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
[TBL] [Abstract][Full Text] [Related]
10. Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.
Odhiambo JO; Kellogg TA; Kim AA; Ng'ang'a L; Mukui I; Umuro M; Mohammed I; De Cock KM; Kimanga DO; Schwarcz S;
J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S116-22. PubMed ID: 24732815
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
[TBL] [Abstract][Full Text] [Related]
12. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression.
Nsubuga-Nyombi T; Sensalire S; Karamagi E; Aloyo J; Byabagambi J; Rahimzai M; Nabitaka LK; Calnan J
AIDS Res Ther; 2018 Mar; 15(1):9. PubMed ID: 29604955
[TBL] [Abstract][Full Text] [Related]
14. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
[TBL] [Abstract][Full Text] [Related]
15. Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.
Kim AA; Parekh BS; Umuro M; Galgalo T; Bunnell R; Makokha E; Dobbs T; Murithi P; Muraguri N; De Cock KM; Mermin J;
PLoS One; 2016; 11(5):e0155498. PubMed ID: 27195800
[TBL] [Abstract][Full Text] [Related]
16. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
17. Tuberculosis and HIV at the national level in Kenya: results from the Second Kenya AIDS Indicator Survey.
Mbithi A; Gichangi A; Kim AA; Katana A; Weyenga H; Williamson J; Robinson K; Oluoch T; Maina WK; Kellogg TA; De Cock KM;
J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S106-15. PubMed ID: 24732814
[TBL] [Abstract][Full Text] [Related]
18. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
[TBL] [Abstract][Full Text] [Related]
19. Engagement in HIV care among Kenyan adults and adolescents: results from a national population-based survey.
Wafula R; Masyuko S; Ng'ang'a L; Kim AA; Gichangi A; Mukui I; Batuka J; Ngugi EW; Maina WK; Schwarcz S;
J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S98-105. PubMed ID: 24732825
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.
Chhim K; Mburu G; Tuot S; Sopha R; Khol V; Chhoun P; Yi S
AIDS Res Ther; 2018 Nov; 15(1):20. PubMed ID: 30445984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
